soul trial oral semaglutide cardiovascular outcomes trial results and in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the Randomized Oral Semaglutide and Cardiovascular Outcomes

Key Takeaways GLP-1 regulation begins in the gut ecosystem SCFAs stimulate GLP-1 secretion Akkermansia supports barrier and mucosal stability Reduced inflammation enhances hormonal sensitivity Microbiome modulation acts upstream of receptor activation Summary Akkermansia muciniphila does not directly produce GLP-1, but it supports upstream mechanisms that regulate its secretion

doi: 10.1074/jbc.270.45.26758 132 DegermanEAhmadFChungYWGuirguisEOmarBStensonLet al

Well check your blood pressure and take a blood sample at your appointment to assess this if you havent been diagnosed yet

Its a small molecule built by ordinary chemistry

J AGAR: (Laughter)